Introduction
During our investigations on the synthesis of optically active organosilicon compounds by use of stereoselective biotransformations, both whole microbial cells [1] [2] [3] [4] [5] [6] and free enzymes [7] were used as biocatalysts (for recent reviews see refs. [8] [9] [10] . The types of reactions studied so far comprise enantioselective reductions, ester hydrolyses, and transesterifications. We report here the enzymatic synthesis of ( R )-(1-aminoethyl)dimethylphenylsilane [( R }-41 starting from racemic dimethylphenyl(l-(phenylacetamido )ethyl]silane ( rac-5) . The optically active (1-aminoethyl)silane ( R )-4 was obtained by a kinetic resolution of rac-5 using immobilized penicillin G acylase (PGA, E.C. 3.5.1.11) from Escherichia coli 5K (pHM 12) as biocatalyst (for a preliminary report on this reaction, see ref. 11) . This type of enzymatic reaction ( amide hydrolysis) has not previously been used for the preparation of optically active organosilicon compounds.
Results and discussion

Synthesis of rac-5
Compound rac-5 was made by a four-step route starting from (chloromethyl)dimethylphenylsilane (1) , as outlined in Scheme 1. Following a procedure described in The silane rac·5 was synthesized for the first time (total yield 41%, based on 1 used). The precursors rac-2-rac-4 have been described previously [16] , but in the present paper a new method for the preparation of rac-2 is described, as are optimized procedures for the synthesis of rac-3 and rac-4.
Enzymatic hydrolysis of rac-5
Preliminary experiments have shown that (R)-4 can be prepared by enantioselective hydrolysis of rac-5 with immobilized PGA as biocatalyst (Scheme 2). The conditions for this bioconversion were optimized by analytical·scale studies [ 11 ] , on The results described here demonstrate that enantioselective biotransformations, with immobilized enzymes as biocatalyst, may be useful for the synthesis of optically active organosilicon compounds on a preparative scale.
Experimental ( a) Chemical syntheses
All reactions were performed in dried solvents under dry nitrogen. Melting points were determined with a Reichelt Thermovar apparatus (without correction).
1 H and 13 C NMR spectra were recorded on a Bruker AM-400 spectrometer operating at 400.1 and 100.6 MHz, respectively. Chemical shifts (ppm) were measured relative to the intemal standard Si(CH 3 ) 4 CH and 13 C, ~ 0). Assignment of the 13 
rac-( 1-Aminoethyl)dimethy/phenylsilane (rac-4)
The procedure was a modification of that described in ref. 16 . A 250 ml glass tube charged with 12.1 g (41.7 mmol) rac-3 and ca. 180 ml of liquid ammonia was placed in a 250 ml autoclave. When the autoclave was heated to 135 o C a pressure of 70-75 bar was reached. The autoclave was kept for 2.5 h under these conditions and then allowed to cool to room temperature. After evaporation of the excess of ammonia, 30 ml of a 6 N aqueous NaOH solution were added and the mixturewas extracted four times with 70 ml portions of diethyl ether. The combined organic layers were dried over Na 2 S0 4 , the solvent was removed in vacuo, and the residue (consisting of a mixture of a white solid and a colourless oil) was fractionally distilled to yield 7.00 g (94%) of a colourless liquid, phosphate buffer (pH 7.5). The reaction was started by adding a solution of 225 mg (756 J.Lmol) rac-5 in 9 ml of DMSO to the mechanically stirred enzyme suspension. After 3 h stirring the reaction was terminated by addition of 100 Inl of ethyl acetate and subsequent removal of the enzyme preparation by filtration (Büchner funnel). The biocatalyst was washed successively three times with 200 ml of ethyl acetate and three tin1es with 300 ml of the buffer solution. The organic and aqueous solutions were combined and the aqueous layer was adjusted to pH < 3 with 6 lv hydrochloric acid. The organic 1ayer was separated and washed twice with ca. 200 ml of 6 N aqueous KOH solution to remove the DMSO, phenylacetic acid, and HCI. The organic extract was dried over Na 2 S0 4 and the solvent evaporated; the solid crude product was purified by recrystallization from acetonitrile at -20 o C to yield 112 mg (50%, related to rac-5) of the unchanged substrate 5. The acidic aqueous layer containing the hydrochloride of the biotransformation product was adjusted to pH 10 with 6 N aqueous KOH solution and then extracted with 800 ml of ethyl acetate. The organic layer was washed twice with ca. 200 ml of 6 N aqueous KOH solution to remove the DMSO and then dried over Na 2 S0 4 . After removal of the solvent in vacuo the crude product was purified by Kugelrohr distillation (80 o CjO.l Torr) to give 54.3 mg (40%. re1ated to rac-5) of ( R )-4 as a colourless liquid which partly crystallized at room temperature to give a solid of m.p. 78 ° C.
The spectroscopic properties of the product were identical with those of chemically prepared rac-4 (see above). 1 H NMR spectroscopic sturlies and GLC analyses of the biotransformation product, after derivatization with (S}-MTPA (see above), revealed the (R)-configuration for the excess enantiomer of 4 and an enantiomeric purity of 92% ee.
